UnitedHealth Group (UNH) stock has strong performance, revenue growth, and potential for substantial gains.

From Nasdaq: 2025-04-03 09:00:00

UnitedHealth Group (UNH) stock has gained +9.9% in the past month, outperforming the Zacks S&P 500 composite. Analysts predict earnings of $7.27 per share for the current quarter, with a +5.2% change from last year. The consensus sales estimate for the current quarter is $111.01 billion, indicating a +11.2% year-over-year change.

Zacks Rank #2 (Buy) for UnitedHealth indicates a positive outlook, with a projected revenue growth of +11.2% for the current quarter. The company has a track record of beating consensus EPS estimates and a strong valuation score of B, suggesting it is trading at a discount compared to peers. The stock is viewed favorably for potential gains.

Zacks.com highlights UnitedHealth as a stock with high potential for significant growth in the coming months. The company’s innovative solutions and growing customer base position it for success. Director of Research Sheraz Mian identifies it as a top pick, with the potential to outperform previous stocks that doubled in value. This stock is one to watch for potential substantial gains.



Read more at Nasdaq: UnitedHealth Group Incorporated (UNH) Is a Trending Stock: Facts to Know Before Betting on It